Celldex Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Celldex Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Celldex Therapeutics Inc Strategy Report
- Understand Celldex Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Celldex Therapeutics Inc (Celldex) is a bio-pharmaceutical company that discovers, develops, and commercializes targeted immunotherapy and other biologics for the treatment of various types of cancers. The company’s developmental pipeline comprises therapeutic antibodies, antibody drug conjugates (ADCs), protein-based therapeutics, immune system modulators and vaccine for unmet medical needs. Its key products in development include CDX-1140; CDX-527, CDX-0159. It’s products find application in the treatment of various indications such as brain cancer, triple negative breast cancer, lymphoma/leukemia, melanoma, and renal cell carcinoma. It operates a manufacturing facility in Massachusetts, the US, and research laboratories in Massachusetts, New Jersey, and Connecticut. Celldex is headquartered in Hampton, New Jersey, the US.
Celldex Therapeutics Inc premium industry data and analytics
Products and Services
Products |
---|
Pipeline:- |
CDX-1140: |
CD40/Oncology |
XYZ |
XYZ |
XYZ |
Competitor Comparison
Key Parameters | Celldex Therapeutics Inc | F. Hoffmann-La Roche Ltd | Merck & Co Inc | Pfizer Inc | AbbVie Inc |
---|---|---|---|---|---|
Headquarters | United States of America | Switzerland | United States of America | United States of America | United States of America |
City | Hampton | Basel | Kenilworth | New York | North Chicago |
State/Province | New Jersey | - | New Jersey | New York | Illinois |
No. of Employees | 160 | 103,605 | 72,000 | 88,000 | 50,000 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Karen L. Shoos | Chairman | Executive Board | 2019 | 69 |
Anthony S. Marucci | Chief Executive Officer; President; Director | Executive Board | 2008 | 61 |
Sam Martin | Secretary; Chief Financial Officer; Senior Vice President | Senior Management | 2017 | 52 |
Diane C. Young, M.D. | Senior Vice President; Chief Medical Officer | Senior Management | 2019 | 67 |
Tibor Keler, Ph.D. | Chief Scientific Officer; Executive Vice President | Senior Management | 2008 | 64 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward